Logo image of IMA

IMAGENEBIO INC (IMA) Stock Earnings & Estimates

USA - NASDAQ:IMA - US45175G1085 - Common Stock

9.14 USD
-0.06 (-0.65%)
Last: 9/12/2025, 8:00:02 PM
7.86 USD
-1.28 (-14%)
After Hours: 9/5/2025, 8:22:30 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
IMA revenue by date.IMA revenue by date.
30.99M
237.21%
15.62M
-49.60%
9.16M
-41.36%

-100.00%
EBITDA
YoY % growth
IMA ebitda by date.IMA ebitda by date.
-33.6M
24.02%
-70.15M
-108.78%
-74.397M
-6.05%
-89.913M
27.33%
-89.897M
-66.28%
N/AN/AN/A
EBIT
YoY % growth
IMA ebit by date.IMA ebit by date.
-34.14M
23.32%
-70.9M
-107.67%
-75.417M
-6.37%
-54.035M
27.66%
-26.23M
51.92%
-39.948M
-52.30%
-67.896M
-69.96%
N/A
Operating Margin
IMA operating margin by date.IMA operating margin by date.
-110.16%-453.91%-823.33%N/AN/AN/AN/AN/A
EPS
YoY % growth
IMA eps by date.IMA eps by date.
-3.20-1.92
40.00%
-1.70
11.46%
-12.00
-399.41%
-5.82
31.48%
-4.65
20.14%
-5.94
-27.83%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-1.29
48.70%
-1.30
43.08%
-0.86
60.25%
-0.80
-10.82%
-0.81
37.50%
-0.88
32.30%
-2.55
-196.47%
-2.91
-264.56%
-3.27
-305.00%
-3.64
-313.79%
Revenue
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-5.439M
53.09%
-6.074M
50.11%
N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.72
78.57%
-1.700.9857.57%
Q1 2025
Q2Q % growth
-2.16
-554.55%
-2.550.3915.13%
Q4 2024
Q2Q % growth
-2.28
-385.11%
-2.300.020.99%
Q3 2024
Q2Q % growth
-2.52
-530.00%
-3.230.7122.03%
Q2 2024
Q2Q % growth
-3.36
-663.64%
-4.210.8520.22%
Q1 2024
Q2Q % growth
-0.33
15.38%
-0.420.0920.79%
Q4 2023
Q2Q % growth
-0.47
-17.50%
-0.43-0.04-8.73%
Q3 2023
Q2Q % growth
-0.40
16.67%
-0.430.037.90%
Q2 2023
Q2Q % growth
-0.44
22.81%
-0.480.048.17%
Q1 2023
Q2Q % growth
-0.39
17.02%
-0.470.0817.39%
Q4 2022
Q2Q % growth
-0.40
-671.43%
-0.480.0816.97%
Q3 2022
Q2Q % growth
-0.48
-20.00%
-0.500.024.07%
Q2 2022
Q2Q % growth
-0.57
-62.86%
-0.49-0.08-15.65%
Q1 2022
Q2Q % growth
-0.47
81.35%
-0.42-0.05-11.33%
Q4 2021
Q2Q % growth
0.07 -0.520.59113.53%
Q3 2021
Q2Q % growth
-0.40 -0.420.025.70%
Q2 2021
Q2Q % growth
-0.35 -0.360.012.80%
Q1 2021
Q2Q % growth
-2.52 -0.69-1.83-267.59%
IMA Yearly EPS VS EstimatesIMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth

-100.00%
%
Q3 2024
Q2Q % growth

-100.00%
%
Q2 2024
Q2Q % growth

-100.00%
%
Q1 2024
Q2Q % growth

-100.00%
1.768M-1.768M-100.00%
Q4 2023
Q2Q % growth
659K
-87.91%
3.169M-2.51M-79.20%
Q3 2023
Q2Q % growth
1.19M
-81.41%
2.573M-1.383M-53.75%
Q2 2023
Q2Q % growth
2M
426.32%
3.113M-1.113M-35.75%
Q1 2023
Q2Q % growth
5.31M
57.10%
4.661M649K13.92%
Q4 2022
Q2Q % growth
5.45M
-73.05%
6.076M-626K-10.30%
Q3 2022
Q2Q % growth
6.4M
70.67%
4.367M2.033M46.55%
Q2 2022
Q2Q % growth
380K
-89.30%
3.913M-3.533M-90.29%
Q1 2022
Q2Q % growth
3.38M
-2.59%
4.614M-1.234M-26.74%
Q4 2021
Q2Q % growth
20.22M
28,785.71%
4.834M15.386M318.29%
Q3 2021
Q2Q % growth
3.75M 4.093M-343K-8.38%
Q2 2021
Q2Q % growth
3.55M
15.64%
3.97M-420K-10.58%
Q1 2021
Q2Q % growth
3.47M 4.43M-960K-21.67%
Q4 2020
Q2Q % growth
70K
-97.50%
%
IMA Yearly Revenue VS EstimatesIMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 10M 20M 30M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% N/A -893.1% N/A
RevenueN/A N/A N/A N/A